Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-05-11
1998-02-17
Ulm, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530399, 435 691, 4353201, 4352523, 435325, A61K 3817
Patent
active
057191255
ABSTRACT:
A novel human chondromodulin-I protein having a molecular weight of about 26,000 dalton on SDS-PAGE and capable of stimulating the growth of chondrocytes with or without FGF, promoting the differential potency of these cells, and inhibiting the growth of vascular endothelial cells, a DNA encoding this protein, expression vector containing the DNA, a transformant capable of producing recombinant chondromodulin-I protein, a process for producing chondromodulin-I protein by culturing the transformant and a pharmaceutical composition containing chondromodulin-I protein as an active ingredient.
REFERENCES:
patent: 5444157 (1995-08-01), Suzuki et al.
Takigawa et al. Anticancer Res. (1990) 10, 311-316.
Hiraki et al. Biochem. Biophys. Res. Comm. (1991) 175, 971-977.
Chemical Abstracts, vol. 115, No. 15, Oct. 14, 1991, Y. Hiraki et al., "Molecular Cloning of a New Class of Cartilage-Specific Matrix, Chondromodulin-I, Which Stimulates Growth of Cultured Chondrocytes", p. 270.
Hiraki Yuji
Kohara Atsuko
Kondo Jun
Mori Akiko
Suzuki Fujio
Brown Karen E.
Mitsubishi Chemical Corporation
Ulm John
LandOfFree
Human chondromodulin-I protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human chondromodulin-I protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human chondromodulin-I protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784050